Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis (2023)
- Authors:
- Silva, Aline Ignacio Silvestre da
- Cipelli, Marcella
- Takiishi, Tatiana
- Aguiar, Cristhiane Favero
- Terra, Fernanda Fernandes
- Nunes, Bruno Ghirotto
- Silva, Eloisa Martins da - Universidade Federal do ABC (UFABC)
- Castoldi, Angela
- Magalhães, Yuli Thamires
- Souza, Tiago Antonio de
- Hiyane, Meire Ioshie
- Oliveira, Vinicius Andrade de
- Forti, Fabio Luis
- Camara, Niels Olsen Saraiva
- USP affiliated authors: HIYANE, MEIRE IOSHIE - ICB ; FORTI, FÁBIO LUÍS - IQ ; CÂMARA, NIELS OLSEN SARAIVA - ICB ; CIPELLI, MARCELLA - ICB ; NUNES, BRUNO GHIROTTO - ICB ; MAGALHÃES, YULI THAMIRES - IQ
- Unidades: ICB; IQ
- DOI: 10.1101/2023.04.26.537895
- Subjects: COLITE; CÉLULAS MIELOIDES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: cc-by-nc-nd
-
ABNT
SILVA, Aline Ignacio Silvestre da et al. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis. bioRxiv, 2023Tradução . . Disponível em: https://doi.org/10.1101/2023.04.26.537895. Acesso em: 03 jun. 2024. -
APA
Silva, A. I. S. da, Cipelli, M., Takiishi, T., Aguiar, C. F., Terra, F. F., Nunes, B. G., et al. (2023). Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis. bioRxiv. doi:10.1101/2023.04.26.537895 -
NLM
Silva AIS da, Cipelli M, Takiishi T, Aguiar CF, Terra FF, Nunes BG, Silva EM da, Castoldi A, Magalhães YT, Souza TA de, Hiyane MI, Oliveira VA de, Forti FL, Camara NOS. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis [Internet]. bioRxiv. 2023 ;[citado 2024 jun. 03 ] Available from: https://doi.org/10.1101/2023.04.26.537895 -
Vancouver
Silva AIS da, Cipelli M, Takiishi T, Aguiar CF, Terra FF, Nunes BG, Silva EM da, Castoldi A, Magalhães YT, Souza TA de, Hiyane MI, Oliveira VA de, Forti FL, Camara NOS. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis [Internet]. bioRxiv. 2023 ;[citado 2024 jun. 03 ] Available from: https://doi.org/10.1101/2023.04.26.537895 - Rho pathway: a fragile point in the GBM resistance to radiotherapy
- Gut microbiota resilience mechanisms against pthogen infection and its role in infammatory Bowel Disease
- The Rho GTPase pathway as a potential chemosensitizer of TMZ and cisplatin-resistant GBM through a p53-dependent mechanism
- Glioblastoma: descoberto mecanismo capaz de reverter resistência do tumor cerebral à radioterapia
- ROCK inhibition reduces the sensitivity of mutant p53 glioblastoma to genotoxic stress through a Rac1-driven ROS production
- Uric acid signalling via adaptor molecule MYD88 and M1/M2 macrophage balance in the development of renal fibrosis
- TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis
- Exogenous leptin modulates acute lung inflammation induced by LPS in mice
- Adipose tissue-derived stem cells reduce acute and chronic kidney damage in mice
- Increased lacrimal inflammatory mediators in patients with keratoconus
Informações sobre o DOI: 10.1101/2023.04.26.537895 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
